EP2044091A4 - COMPOUNDS FOR TREATING A PERIODONTAL DISEASE - Google Patents

COMPOUNDS FOR TREATING A PERIODONTAL DISEASE

Info

Publication number
EP2044091A4
EP2044091A4 EP07812123A EP07812123A EP2044091A4 EP 2044091 A4 EP2044091 A4 EP 2044091A4 EP 07812123 A EP07812123 A EP 07812123A EP 07812123 A EP07812123 A EP 07812123A EP 2044091 A4 EP2044091 A4 EP 2044091A4
Authority
EP
European Patent Office
Prior art keywords
treating
compounds
periodontal disease
periodontal
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07812123A
Other languages
German (de)
French (fr)
Other versions
EP2044091A2 (en
Inventor
Virginia Sanders
Kirk R Maples
Jacob J Plattner
Carolyn Bellinger-Kawahara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anacor Pharmaceuticals LLC
Original Assignee
Anacor Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals LLC filed Critical Anacor Pharmaceuticals LLC
Publication of EP2044091A2 publication Critical patent/EP2044091A2/en
Publication of EP2044091A4 publication Critical patent/EP2044091A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
EP07812123A 2006-06-12 2007-06-12 COMPOUNDS FOR TREATING A PERIODONTAL DISEASE Withdrawn EP2044091A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80450406P 2006-06-12 2006-06-12
US82389306P 2006-08-29 2006-08-29
PCT/US2007/071049 WO2007146965A2 (en) 2006-06-12 2007-06-12 Compounds for the treatment of periodontal disease

Publications (2)

Publication Number Publication Date
EP2044091A2 EP2044091A2 (en) 2009-04-08
EP2044091A4 true EP2044091A4 (en) 2010-08-04

Family

ID=38832802

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07812123A Withdrawn EP2044091A4 (en) 2006-06-12 2007-06-12 COMPOUNDS FOR TREATING A PERIODONTAL DISEASE

Country Status (9)

Country Link
EP (1) EP2044091A4 (en)
KR (1) KR20090029797A (en)
AU (1) AU2007257689A1 (en)
BR (1) BRPI0713010A2 (en)
CA (1) CA2654449A1 (en)
IL (1) IL195571A0 (en)
MX (1) MX2008015918A (en)
RU (1) RU2008152367A (en)
WO (1) WO2007146965A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767657B2 (en) 2005-02-16 2010-08-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
JP5038912B2 (en) 2005-02-16 2012-10-03 アナコール ファーマシューティカルズ,インコーポレイテッド Boron-containing small molecule
NZ570257A (en) 2006-02-16 2011-11-25 Anacor Pharmaceuticals Inc Boron-containing small molecules as anti-inflammatory agents
JO3598B1 (en) 2006-10-10 2020-07-05 Infinity Discovery Inc Boronic acids and esters as inhibitors of fatty acid amide hydrolase
JO3396B1 (en) 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc Boron-containing small molecules
BRPI0908565A2 (en) 2008-03-06 2017-05-23 Anacor Pharmaceuticals Inc compound, pharmaceutical formulation, methods for reducing the release of a cytokine or chemokine, treating a condition in an animal and inhibiting a phosphodiesterase
AU2009233711B2 (en) 2008-04-09 2015-02-12 Infinity Pharmaceuticals, Inc Inhibitors of fatty acid amide hydrolase
JP5606913B2 (en) * 2008-08-11 2014-10-15 独立行政法人科学技術振興機構 Protein cross-linking inhibitor
EP2348863A4 (en) 2008-09-04 2012-03-07 Anacor Pharmaceuticals Inc SMALL MOLECULES CONTAINING BORON
US8461336B2 (en) 2008-09-04 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US9493489B2 (en) 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
MX2011006334A (en) 2008-12-17 2011-09-22 Anacor Pharmaceuticals Inc Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c] [1,2] oxaborol-1-ol.
WO2010118159A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
EP2416660B1 (en) 2009-04-07 2014-07-02 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
TW201109022A (en) * 2009-06-03 2011-03-16 Colgate Palmolive Co Borinic compositions
KR20130031233A (en) 2009-07-28 2013-03-28 아나코르 파마슈티칼스 인코포레이티드 Trisubstituted boron-containing molecules
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
WO2011049971A1 (en) 2009-10-20 2011-04-28 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US20110212918A1 (en) 2009-11-11 2011-09-01 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011063293A1 (en) * 2009-11-20 2011-05-26 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antihelminth agents
RU2414210C1 (en) * 2009-12-28 2011-03-20 Общество С Ограниченной Ответственностью "Сплат-Косметика" (Ооо "Сплат-Косметика") Medication for removal of tobacco resins and based on it composition
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
EP2531511A1 (en) 2010-02-03 2012-12-12 Infinity Pharmaceuticals, Inc. Fatty acid amide hydrolase inhibitors
AP2012006482A0 (en) 2010-03-19 2012-10-31 Anacor Pharmacueticals Inc Boron-containing small molecules as anti-protozoalagent
SG10201507032YA (en) 2010-09-07 2015-10-29 Anacor Pharmaceuticals Inc Benzoxaborole derivatives for treating bacterial infections
AR088668A1 (en) * 2011-11-21 2014-06-25 Lilly Co Eli SMALL MOLECULES CONTAINING BORO
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
DK2950644T3 (en) 2013-01-30 2017-09-04 Agrofresh Inc USE OF BENZOXABOROLS AS VOLATIVE ANTIMICROBIAL AGENTS IN MEAT, PLANTS OR PARTS
JP6605513B2 (en) 2014-07-01 2019-11-13 第一三共株式会社 Tricyclic benzoxabolol as an antibacterial agent
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
US11447506B2 (en) 2016-05-09 2022-09-20 Anacor Pharmaceuticals, Inc. Crystal forms of crisaborole in free form and preparation method and use thereof
BR112018073017B1 (en) * 2016-05-09 2022-06-14 Anacor Pharmaceuticals, Inc CRYSTALLINE FORM I OF CHRYSABOROLE IN FREE FORM, METHOD OF PREPARATION AND USE
CN107759625B (en) * 2016-08-22 2020-12-29 药源药物化学(上海)有限公司 Preparation method of 4- (1-hydroxy-1, 3-dihydrobenzo [ c ] [1,2] oxaborole-5-yloxy) benzonitrile
EP3609504A4 (en) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. NOVEL OXABOROL ANALOGA AND USES THEREOF
WO2018164959A1 (en) * 2017-03-09 2018-09-13 The Penn State Research Foundation Boron-containing small molecules for inhibiting activity of a receptor-like protein tyrosine phosphatase
CN110183477B (en) * 2019-07-03 2022-03-04 石家庄诚志永华显示材料有限公司 Organic electroluminescent compounds and their applications
EP4204012A1 (en) 2020-08-31 2023-07-05 Pfizer Inc. Methods of protecting rna
KR102638321B1 (en) * 2022-01-27 2024-02-19 마이크로바이오헬스케어 주식회사 Novel compound with anti-biofilm formation activity and use of the same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1155698A1 (en) * 1999-01-29 2001-11-21 Nitto Kasei Co., Ltd. Organoboron compounds exhibiting anticoccidial activities
WO2004056322A2 (en) * 2002-12-18 2004-07-08 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
WO2005021559A2 (en) * 2003-09-02 2005-03-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oxazaborolidines as bacteria effectors
WO2005123094A2 (en) * 2004-06-14 2005-12-29 Anacor Pharmaceuticals, Inc. Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones
WO2005123095A1 (en) * 2004-06-14 2005-12-29 Anacor Pharmaceuticals, Inc. Anti-parasitic uses of borinic acid complexes
WO2006007384A2 (en) * 2004-06-14 2006-01-19 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716035A (en) * 1985-05-24 1987-12-29 The Procter & Gamble Company Oral compositions and methods for treating gingivitis

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1155698A1 (en) * 1999-01-29 2001-11-21 Nitto Kasei Co., Ltd. Organoboron compounds exhibiting anticoccidial activities
WO2004056322A2 (en) * 2002-12-18 2004-07-08 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
WO2005021559A2 (en) * 2003-09-02 2005-03-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oxazaborolidines as bacteria effectors
WO2005123094A2 (en) * 2004-06-14 2005-12-29 Anacor Pharmaceuticals, Inc. Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones
WO2005123095A1 (en) * 2004-06-14 2005-12-29 Anacor Pharmaceuticals, Inc. Anti-parasitic uses of borinic acid complexes
US20060009422A1 (en) * 2004-06-14 2006-01-12 David Perry Boron-containing compounds and methods of use
WO2006007384A2 (en) * 2004-06-14 2006-01-19 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use

Also Published As

Publication number Publication date
EP2044091A2 (en) 2009-04-08
AU2007257689A1 (en) 2007-12-21
IL195571A0 (en) 2009-09-01
WO2007146965A3 (en) 2008-12-04
WO2007146965A2 (en) 2007-12-21
CA2654449A1 (en) 2007-12-21
MX2008015918A (en) 2009-01-14
RU2008152367A (en) 2010-07-20
KR20090029797A (en) 2009-03-23
BRPI0713010A2 (en) 2012-10-09

Similar Documents

Publication Publication Date Title
EP1922023A4 (en) METHOD FOR TREATING A MYOCARDIAL BREAK
EP2119443A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF A THROMBUS OR EMBOLE RELATED DISEASE
IL195571A0 (en) Compounds for the treatment of periodontal disease
EP1919287A4 (en) ORGANIC COMPOUNDS FOR TREATING A REDUCED DOPAMINE RECEPTOR ACTIVITY SIGNAL
EP2200441A4 (en) COMPOSITION AND METHOD FOR PREVENTING ORAL DISEASE
EP1966183A4 (en) HETEROAROMATIC COMPOUNDS AS DELTA-9 DEATURASE STÉAROYL-COENZYME INHIBITORS
DK2533050T6 (en) Treatment options for Fabry's disease
EP1976790A4 (en) ELEVATOR ACTUATOR
BRPI0719626A2 (en) '' COMPOUND ''
EP2141985A4 (en) TRANSGENIC ANIMAL MODELS FOR DISEASE
EP2035369A4 (en) THERAPEUTIC COMPOUNDS
FR2916627B1 (en) NECESSARY FOR TREATING A BLOOD CIRCULATION CONDUIT
EP2076207A4 (en) DIGITAL PLANNING OF ORTHODONTIC TREATMENT
EP2088861A4 (en) BENZIMIDAZOLE COMPOUNDS
BRPI0717671A2 (en) "DENTAL IRRIGATOR"
EP1977009A4 (en) ADENOVIRUS ADIPOGENES AS A BIOMARKER OF A DISEASE
EP2140882A4 (en) AGENT FOR THE TREATMENT OF PULMONARY DISEASE
EP2379075A4 (en) TRIAZOLE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP1986660A4 (en) HEXOSE-BASED COMPOUNDS FOR TREATING CANCER
EP2210621A4 (en) COMPOSITION FOR TREATING JOINT DISEASE
EP1960549A4 (en) Fc-GAMMA POLYMORPHISMS FOR PREDICTING A DISEASE AND THE RESULTS OF TREATMENT
EP2344881A4 (en) BIOMARKERS FOR ALZHEIMER'S DISEASE
EP2162377A4 (en) ELEVATOR SHEATH
EP2151451A4 (en) COMPOSITION FOR PREVENTING OR TREATING PULMONARY DISEASE
EP2252277A4 (en) ACETYL-MIMETIC COMPOUNDS FOR INHIBITING ISOPRENYL-S-CYSTEINEYL METHYLTRANFERASE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090109

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ANACOR PHARMACEUTICALS, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 11/00 20060101ALI20090519BHEP

Ipc: A61K 31/69 20060101ALI20090519BHEP

Ipc: C07F 5/05 20060101ALI20090519BHEP

Ipc: C07F 5/02 20060101ALI20090519BHEP

Ipc: C07F 5/00 20060101AFI20090519BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1129680

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20100706

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110208

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1129680

Country of ref document: HK